Outcomes research myths and realities

Circulation: Cardiovascular Quality and Outcomes

Volumn 2, Issue 1, 2009, Pages 1-3

  Krumholz, Harlan M ^a,b,c  

^a Robert Wood Johnson Clinical Scholars Program   (United States)

^b YALE UNIVERSITY   (United States)

^c YALE NEW HAVEN HOSPITAL   (United States)

Author keywords

Outcomes research

Indexed keywords

CLINICAL PRACTICE; DECISION MAKING; EPIDEMIOLOGICAL DATA; HEALTH CARE ORGANIZATION; HEALTH CARE SYSTEM; MEDICAL CARE; MEDICAL LITERATURE; MEDICAL RESEARCH; OBSERVATIONAL STUDY; OUTCOMES RESEARCH; PATIENT CARE; POLICY; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; REVIEW; SCIENTIFIC LITERATURE; ARTICLE; EVIDENCE BASED MEDICINE; HEALTH CARE POLICY; HEALTH SERVICES RESEARCH; HUMAN; METHODOLOGY; NOMENCLATURE; QUALITY OF LIFE; TREATMENT OUTCOME;

EVIDENCE-BASED MEDICINE; HEALTH CARE REFORM; HEALTH SERVICES RESEARCH; HUMANS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); QUALITY OF LIFE; TERMINOLOGY AS TOPIC; TREATMENT OUTCOME;

EID: 63849206423     PISSN: 19417713     EISSN: 19417705     Source Type: Journal    
DOI: 10.1161/CIRCOUTCOMES.108.844035     Document Type: Review

References (24)

1. Krumholz HM. Outcomes research: generating evidence for best practice and policies. Circulation. 2008; 118: 309-318.
2. Ellwood PM. Shattuck lecture-outcomes management: a technology of patient experience. N Engl J Med. 1988; 318: 1549-1556.
3. Clancy CM, Eisenberg JM. Outcomes research: measuring the end results of health care. Science. 1998; 282: 245-246.
4. Hearing before a subcommittee of the Committee on Appropriations. One Hundred Fifth Congress, Second Session, Part 3. Washington, DC: Department of Health and Human Services; 1998.
5. Chan PS, Nallamothu BK, Spertus JA, Masoudi FA, Bartone C, Kereiakes DJ, Chow T. Impact of age and medical comorbidity on the effectiveness of implantable cardioverter-defibrillators for primary prevention. Circ Cardiovasc Qual Outcomes. 2009; 2: 16-24.
6. Concannon TW, Griffith JL, Kent DM, Normand S-LT, Newhouse JP, Atkins J, Beshansky JR, Selker HP. Elapsed time in emergency medical services for patients with cardiac complaints: are some patients at greater risk for delay? Circ Cardiovasc Qual Outcomes. 2009; 2: 9-15.
7. Keenan PS, Normand S-LT, Lin Z, Drye EE, Bhat KR, Ross JS, Schuur JD, Stauffer BD, Bernheim SM, Epstein AJ, Wang Y-F, Herrin J, Chen J, Federer JJ, Mattera JA, Wang Y, Krumholz HM. An administrative claims measure suitable for profiling hospital performance on the basis of 30-day all-cause readmission rates among patients with heart failure. Circ Cardiovasc Qual Outcomes. 2008; 1: 29-37.
8. Nallamothu BK, Lu X, Vaughan-Sarrazin MS, Cram P. Coronary revascularization at specialty cardiac hospitals and peer general hospitals in black Medicare beneficiaries. Circ Cardiovasc Qual Outcomes. 2008; 1: 116-122.
9. Norris CM, Spertus JA, Jensen L, Johnson J, Hegadoren KM, Ghali WA, for the APPROACH Investigators. Sex and gender discrepancies in health-related quality of life outcomes among patients with established coronary artery disease. Circ Cardiovasc Qual Outcomes. 2008; 1: 123-130.
10. Pasquali SK, Hall M, Slonim AD, Jenkins KJ, Marino BS, Cohen MS, Shah SS. Off-label use of cardiovascular medications in children hospitalized with congenital and acquired heart disease. Circ Cardiovasc Qual Outcomes. 2008; 1: 74-83.
11. Arnold SV, Decker C, Ahmad H, Olabiyi O, Mundluru S, Reid KJ, Soto GE, Gansert S, Spertus JA. Converting the informed consent from a perfunctory process to an evidence-based foundation for patient decision making. Circ Cardiovasc Qual Outcomes. 2008; 1: 21-28.
12. Mahoney EM, Wang K, Cohen DJ, Hirsch AT, Alberts MJ, Eagle K, Mosse F, Jackson JD, Steg PG, Bhatt DL; on behalf of the REACH Registry Investigators. One-year costs in patients with a history of or at risk for atherothrombosis in the United States. Circ Cardiovasc Qual Outcomes. 2008; 1: 38-45.
13. Parashar S, Rumsfeld JS, Reid KJ, Buchanan D, Dawood N, Khizer S, Lichtman JH, Vaccarino V. Women, depression, and outcome of myocardial infarction. Circ Cardiovasc Qual Outcomes. 2009; 2: 33-40.
14. Wilson PWF, Pencina M, Jacques P, Selhub J, D'Agostino R Sr, O'Donnell CJ. C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study. Circ Cardiovasc Qual Outcomes. 2008; 1: 92-97.
15. Arnold SV, Morrow DA, Wang K, Lei Y, Mahoney EM, Scirica BM, Braunwand E, Cohen DJ; on behalf of the MERLIN-TIMI 36 Investigators. Effects of ranolazine on disease-specific health status and quality of life among patients with acute coronary syndromes: results from the MERLIN-TIMI 36 randomized trial. Circ Cardiovasc Qual Outcomes. 2008; 1: 107-115.
16. Mosca L, Mochari H, Liao M, Christian AH, Edelman DJ, Aggarwal B, Oz MC. A novel family-based intervention trial to improve heart health-FIT Heart: results of a randomized controlled trial. Circ Cardiovasc Qual Outcomes. 2008; 1: 98-106.
17. Orth-Gomér K, Schneiderman N, Wang H, Walldin C, Blom M, Jernberg T. Stress reduction prolongs life in women with coronary disease: the Stockholm Women's Intervention Trial for Coronary Heart Disease. Circ Cardiovasc Qual Outcomes. 2009; 2: 25-32.
18. Weintraub WS, Boden WE, Zhang Z, Kolm P, Zhang Z, Spertus JA, Hartigan P, Veledar E, Jurkovitz C, Bowen J, Maron DJ, O'Rourke R, Dada M, Teo KK, Goeree R, Barnett PG; on behalf of the Department of Veterans Affairs Cooperative Studies Program No. 424 (COURAGE Trial) Investigators and Study Coordinators. Cost-effectiveness of percutaneous coronary intervention in optimally treated stable coronary patients. Circ Cardiovasc Qual Outcomes. 2008; 1: 12-20.
19. Angell SY, Garg RK, Gwynn RC, Bash L, Thorpe LE, Frieden TR. Prevalence, awareness, treatment, and predictors of control of hypertension in New York City. Circ Cardiovasc Qual Outcomes. 2008; 1: 46-53.
20. Spatz ES, Canavan ME, Desai MM. From here to JUPITER: identifying new patients for statin therapy using data from the 1999-2004 National Health and Nutrition Examination Survey. Circ Cardiovasc Qual Outcomes. 2009; 2: 41-48.
21. Wan Y, Heneghan C, Perera R, Roberts N, Hollowell J, Glasziou P, Bankhead C, Xu Y. Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review. Circ Cardiovasc Qual Outcomes. 2008; 1: 84-91.
22. Ho PM, Peterson PN, Masoudi FA. Evaluating the evidence: is there a rigid hierarchy? Circulation. 2008; 118: 1675-1684.
23. Bradley EH, Curry LA, Webster TR, Mattera JA, Roumanis SA, Radford MJ, McNamara RL, Barton BA, Berg DN, Krumholz HM. Achieving rapid door-to-balloon times: how top hospitals improve complex clinical systems. Circulation. 2006; 113: 1079-1085. (Pubitemid 43754274)
24. Woolf SH. The meaning of translational research and why it matters. JAMA. 2008; 299: 211-213.